###### Oncology
# In fighting cancer, look to what other animals do 
![image](images/20190629_STP001_1.jpg) 
> print-edition iconPrint edition | Science and technology | Jun 29th 2019 
IN 1977 RICHARD PETO, an epidemiologist at Oxford University, observed a contradiction. Cancer begins as a mutation in a single cell. Organisms with more cells should therefore have a higher risk of developing it. Elephants, which have 100 times as many cells as human beings do, should swarm with malignancies. Whales, with ten times more again, should be barnacled with tumours. In fact, the planet’s behemoths are blessed with extremely low rates of cancer. Titanic bodies and tumour resistance have evolved in tandem. The secret of suppressing cancer may therefore be hidden in the genes of giants. 
Inspired by Peto’s paradox, as this contradiction has come to be known, researchers are exploring rates of cancer and resistance to cancer in thousands of animal species, with an emphasis on heavyweights. Their hope is to translate the animals’ cancer-fighting talents into treatments for people. 
In one recent study, published in Molecular Biology and Evolution and entitled “Return to the sea, get huge, beat cancer”, Marc Tollis of Northern Arizona University and his colleagues sequenced the genome of the humpback whale and began trawling through it for tumour-suppressor genes. Previous research had revealed that, around 50m years ago, creatures which looked something like a cross between a rat and a wolf dog-paddled into the sea and eventually evolved into whales. These animals remained fairly small until about 3m years ago. Then they rapidly ballooned into whoppers the size of buses. 
Dr Tollis found that as ancestral whales grew, numerous alterations to their tumour-suppressor genes hopped on board. He and his colleagues identified 33 known tumour-suppressing genes in humpback whales that showed evidence of advantageous changes. These included ATR, which detects damage to DNA and halts the cycle of cell division that cancer-promoting mutations encourage; AMER1, which stifles cell growth; and RECK, which reins in metastasis, the tendency of cancer cells to peel off their natal tumour and wander around the body looking for other sites to colonise. Humpback whales also have duplications in genes that promote apoptosis, the process that commands mutated cells to commit suicide. All this suggests that the evolution of gigantism in cetaceans is associated with strong selective pressure in favour of genes that conquer cancer. 
Cancer biologists are familiar with ATR, AMER1 and RECK because people have them too. But whales may also harbour tumour-fighting genes unknown to science. The next step is therefore to irradiate laboratory-grown lines of whale cells, in order to encourage cancer-causing mutations and thus find out which genes become active in an attempt to clamp down on those mutations. The eventual goal is to discover which strategies whale genes use to combat cancer. Researchers will do this by transferring whale genes into human cell lines, zapping those cells with radiation, then seeing if the whale genes attempt to repair the DNA damage—as human genes often do—or opt for the often more effective method of triggering apoptosis. 
Similar studies are already being done using cancer-fighting proteins from another group of giants—elephants. These have a cancer-mortality rate of about 5%, compared with 11-25% in human populations. Some participants in the whale study were previously involved in sequencing African and Asian elephant genomes. They found that an important weapon in the elephants’ arsenal is TP53, a gene that encodes an apoptosis-inducing protein called p53. This protein is known colloquially as “the guardian of the genome”. 
Human beings have two copies of TP53 in their chromosomes—one from each parent. Those in whom one of these does not work manifest a condition called Li-Fraumeni syndrome, and are almost certain to develop cancer. Elephants’ chromosomes, by contrast, sport 40 versions of TP53—part of the explanation, surely, of why elephant tumours are so rare. 
Joshua Schiffman, a paediatric oncologist at the Huntsman Cancer Institute in Utah who was involved in the elephant study, is investigating how elephants’ multiple copies of TP53 co-ordinate an attack on mutated cells. He is also studying how slight differences in the composition of elephant p53 make it a more efficient mutant-cell killer than its human counterpart. The power of elephant p53 led Dr Schiffman to co-found PEEL Therapeutics, based in Utah and Israel (the firm’s name is derived from the Hebrew word for elephant). PEEL’s purpose is to translate discoveries in comparative oncology into human patients. The firm’s researchers are experimenting with minuscule lipid spheres loaded with proteins, including synthetic elephant p53. Their most promising experimental drug is designed to deliver this directly to a patient’s tumour cells. Details are still under wraps, but Dr Schiffman says that, in a laboratory, introducing synthetic elephant p53 to human cancer cells induces “incredibly rapid and robust cell death”. 
These studies on elephants and whales are part of a larger effort in comparative oncology—some of it based at Arizona State University’s Arizona Cancer Evolution Centre (ACE). Researchers at ACE, including Dr Tollis and the centre’s director, Carlo Maley, are looking at cancer rates in 13,000 animal species, using more than 170,000 records of individual animals. This study is the first of its kind, and is intended to search for patterns that might explain resistance and susceptibility to tumours. To this end the researchers are casting their net wide. They have, for example, attempted to induce tumours in sponges that have no reported incidence of cancer. 
Dr Tollis, Dr Maley and their colleagues will also search for tumour-suppressing genes in previously sequenced genomes available in public databases. These include about 65 species of mammal—some of which, such as naked mole rats, are noted for low cancer rates even though they are small compared with elephants and whales, and so do not seem to conform to Peto’s paradox. The search will also look at non-mammalian exceptions to the paradox, such as crocodiles and birds. Dr Tollis and Dr Maley speculate that birds, at least, inherited their cancer resistance from dinosaur ancestors which were much larger. They are working on computational models to test this hypothesis. 
One novel aspect of all this research is its willingness to take the animals under study on their own terms. Medical science uses animals a lot—but almost always they are there to act as stand-ins for human beings, a role encapsulated in the word “model” that is often applied to such laboratory organisms. Comparative oncology explicitly rejects this idea. Instead, it studies a phenomenon, namely cancer and the body’s response to it, without prejudice, and only then attempts to draw medically useful lessons. Whether that approach might be extended to other fields of medicine is surely worth consideration.◼ 
-- 
 单词注释:
1.oncology[ɒŋ'kɒlәdʒi]:n. 肿瘤学 [医] 肿瘤学 
2.Jun[dʒʌn]:六月 
3.richard['ritʃәd]:n. 理查德（男子名） 
4.Peto['peitәu]:刺鲅 
5.epidemiologist['epi,di:mi'ɔlәdʒist]:n. 流行病学家 
6.Oxford['ɒksfәd]:n. 牛津, 牛津大学 
7.mutation[mju:'teiʃәn]:n. 变化, 突变, 元音变化 [化] 突变 
8.malignancy[mә'lignәnsi]:n. 恶意, 邪恶, 恶性肿瘤 [医] 恶性 
9.barnacle['bɑ:nәkl]:n. 北极雁, 藤壶 
10.tumour['tju:mә]:n. 瘤, 肿块 
11.behemoth[bi'hi:mɔθ]:n. 庞然大物 
12.Titanic[tai'tænik]:a. 四价钛的 [化] 钛; 正钛; 四价钛 
13.tandem['tændәm]:adv. 一前一后地, 纵排地 a. 纵排的, 串联的 n. 纵列两匹马拉的马车, 前后纵列的两匹马, 串座双人自行车 
14.suppress[sә'pres]:vt. 镇压, 使止住, 禁止, 抑制, 查禁 [法] 镇压, 平定, 禁止出版 
15.paradox['pærәdɒks]:n. 似非而是的论点, 自相矛盾的话, 悖论, 怪人怪事 [化] 佯谬 
16.specie['spi:ʃi]:n. 硬币 [经] 硬币 
17.heavyweight['heviweit]:n. 重量级拳击运动员, (非正式)有影响的要人 a. 最重量级的 
18.molecular[mә'lekjulә]:a. 分子的, 由分子组成的 [医] 分子的 
19.marc[mɑ:k]:n. 榨渣 [计] 机器可读目录; 机读目录 
20.tollis[]:托利斯 
21.Arizona[æri'zәunә]:n. 亚利桑那州 
22.genome['dʒi:nәum]:[化] 基因组 [医] 染色体组 
23.humpback['hʌmpbæk]:n. 驼背(者), 细鳞大马哈鱼 [医] 脊柱后突, 驼背 
24.trawl[trɒ:l]:n. 拖网 v. 用拖网捕鱼 
25.whopper['hwɒpә]:n. 特大之物, 弥天大谎 
26.ancestral[æn'sestrәl]:a. 祖先的, 祖传的 [法] 祖先的, 祖传的 
27.alteration[.ɒ:ltә'reiʃәn]:n. 变更, 改动 [医] 变更 
28.hop[hɒp]:n. 单脚跳, 跳跃, 舞会, 飞行 vi. 单脚跳, 跳跃 vt. 跃过, 跳上, 加蛇麻子于, 服麻醉药 [计] 跳跃式传输 
29.advantageous[.ædvәn'teidʒәs]:a. 有利的, 有益的 
30.ATR[]:[计] 属性, 标志 
31.DNA[]:脱氧核糖核酸 [计] 无效数据, 数字网络体系结构, 分布式网络体系结构 
32.stifle['staifl]:vt. 使窒息, 抑止, 扼杀 vi. 窒息, 被扼杀 
33.reck[rek]:vt. 介意, 和...相关 vi. 有关系, 介意 
34.metastasis[mә'tæstәsis]:n. 转移, 新陈代谢, 移位变化 [化] 移位变化; 失α-微粒变化; 转移 
35.natal['neitl]:a. 出生的, 诞生的 [医] 分娩的, 生产的; 臀的 
36.colonise['kɔlәnaiz]:vi. 开拓殖民地；移民于殖民地 
37.humpback['hʌmpbæk]:n. 驼背(者), 细鳞大马哈鱼 [医] 脊柱后突, 驼背 
38.duplication[.dju:pli'keiʃәn]:n. 副本, 复制 [医] 重迭, 双折, 复制 
39.apoptosis[,æpə(p)'təʊsɪs]:n. 细胞凋亡；细胞死亡 
40.mutate['mju:teit]:vi. 变化, 产生变异, 变化元音 vt. 使变异 
41.suicide['sjuisaid]:n. 自杀, 自杀者 v. 自杀 a. 自杀的 
42.gigantism['dʒai^æntizәm]:n. 巨大, 巨体, 巨大发育, 巨大畸形, 庞大 [医] 巨大发育, 巨人症 
43.cetacean[si'teiʃjәn]:a. 鲸目的, 鲸鱼的 n. 鲸目动物, 鲸鱼 
44.selective[si'lektiv]:a. 选择的, 选择性的 [经] 选择的, 选择性的 
45.biologist[bai'ɒlәdʒist]:n. 生物学家 [医] 生物学家 
46.irradiate[i'reidieit]:vt. 照耀, 启发, 使灿烂, 放射 vi. 发光, 变灿烂 
47.clamp[klæmp]:n. 夹钳 vt. 夹紧, 强加 
48.eventual[i'ventʃuәl]:a. 最后的, 终于的 
49.combat['kɒmbæt]:n. 争斗, 战斗 vi. 战斗, 争斗 vt. 与...战斗, 与...斗争 
50.zap[zæp]:vt. 杀死, 快速推动, 闪电般击中 vi. 快速移动 n. 活力, 精力, 震击 interj. (表示快速)嚓 
51.opt[ɒpt]:vi. 选择 
52.trigger['trigә]:n. 触发器, 扳机 vt. 触发, 发射, 引起 vi. 松开扳柄 [计] 切换开关 
53.participant[pɑ:'tisipәnt]:n. 参加者, 参与者 a. 有份的, 参加的, 参与的 
54.arsenal['ɑ:snәl]:n. 兵工厂, 军械库 [机] 兵工厂 
55.encode[in'kәud]:vt. 把(电文、情报等)译成密码 [计] 编码 
56.colloquially[kә'lәukwiәli]:adv. 用口语, 用通俗语 
57.guardian['gɑ:diәn]:n. 看守者, 监护人, 保护人 a. 保护的 
58.manifest['mænifest]:n. 载货单, 运货单, 旅客名单 a. 显然的, 明白的 vi. 显示, 出现 vt. 表明, 表现, 证明 
59.syndrome['sindrәum]:n. 并发症状, 综合征, 同时存在的事物 [计] 校验子; 并发位 
60.chromosome['krәumәsәum]:n. 染色体 [化] 染色体 
61.Joshua['dʒɒʃuә]:n. 约书亚(<<圣经>>人物), <<约书亚记>> 
62.schiffman[]: [人名] 希夫曼 
63.paediatric[.pi:di'ætrik]:a. 儿科的 
64.oncologist[]:n. 肿瘤学家；肿瘤医师 
65.huntsman['hʌntsmәn]:n. 猎人, 管猎犬者 
66.Utah['ju:tɑ:]:n. 犹他 
67.killer['kilә]:n. (非正式)杀人者, 屠杀者, 猛兽, 致死(疾病), 杀手, 止痛药, 限制器, 瞄准器 [计] 删除程序; 断路器 
68.counterpart['kauntәpɑ:t]:n. 副本, 复本, 配对物, 相应物 [经] 副本, 正副二份中之一 
69.therapeutics[.θerә'pju:tiks]:n. 治疗学 [医] 治疗学; 疗法, 治疗 
70.Israel['izreil]:n. 以色列, 以色列后裔, 犹太人 
71.Hebrew['hi:bru:]:n. 希伯来人, 希伯来语, 犹太人 a. 希伯来人的, 希伯来语的 
72.oncology[ɒŋ'kɒlәdʒi]:n. 肿瘤学 [医] 肿瘤学 
73.minuscule['minәskju:l]:n. 小书写体, 小写字 a. 用小书写体的, 小写字的 
74.lipid['lipid, 'laipid]:n. 脂类, 类脂物, 脂质 [化] 类脂; 脂质; 脂类 
75.induce[in'dju:s]:vt. 引诱, 招致, 归纳出, 感应 [医] 诱导, 感应 
76.incredibly[in'kredәbli]:adv. 不能相信地 
77.robust[rәu'bʌst]:a. 健康的, 强健的, 要用力气的, 坚定的, 粗野的 [计] 健壮性 
78.ace[eis]:n. 幺点, 好手, 少许, 发球得分 a. 一流的, 杰出的 [计] 应答允许, 自适应计算机试验, 自动呼叫设备, 自动执行控制 
79.carlo[]:n. 卡洛（男子名） 
80.maley[]: [人名] 梅利 
81.susceptibility[sә.septә'biliti]:n. 敏感性, 感情 [电] 磁化系数 
82.incidence['insidәns]:n. 发生, 发生率, 影响, 负担者, 入射, 倾角 [医] 入射, 发生率, 发生数 
83.mole[mәul]:n. 痣, 鼹鼠, 防波堤, 摩尔, 克分子 [化] 摩尔 
84.conform[kәn'fɒ:m]:vt. 使一致, 使遵守, 使符合 vi. 一致, 符合, 适应 
85.crocodile['krɒkәdail]:n. 鳄鱼 
86.speculate['spekjuleit]:vi. 深思, 推测, 投机 [经] 投机 
87.computational[.kɒmpju'teiʃәnәl]:a. 计算的 
88.hypothesis[hai'pɒθәsis]:n. 假设 [化] 假设 
89.alway['ɔ:lwei]:adv. 永远；总是（等于always） 
90.encapsulate[in'kæpsәleit]:vt. 装入胶囊, 封进内部, 压缩 vi. 做成胶囊 
91.explicitly[]:adv. 明确地；明白地 
92.medically[]:adv. 医学, 医疗, 医术, 内科, 医药 
